Medications

FDA panel backs Pfizer drug for kidney cancer

(AP) -- A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman.

Oncology & Cancer

Novel treatment for skin lymphoma

Promising findings on a novel combination treatment approach for a chronic type of skin lymphoma are being published today (embargoed for 4 pm) in JAMA's Archives of Dermatology by clinical researchers from Seidman Cancer ...

Oncology & Cancer

Cervical cancer vaccine shows promise

A vaccine against cervical cancer, being developed by Inovio Pharmaceuticals Inc. of Blue Bell, Pa., produced positive results in a small sample of 18 women.

Oncology & Cancer

Prophylaxis with apixaban feasible for cancer patients

(HealthDay) -- Primary venous thromboembolism prophylaxis with apixaban, an oral direct Factor Xa inhibitor, in ambulatory cancer patients undergoing first- or second-line chemotherapy for advanced or metastatic cancer, is ...

Oncology & Cancer

Pfizer breast cancer drug gets breakthrough label

Pfizer Inc. says its experimental pill for advanced, often deadly breast cancer has been designated as a breakthrough therapy by the Food and Drug Administration.

Medications

FDA expands approval of Bayer cancer drug (Update)

The U.S. Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that do not respond to other treatments.

Oncology & Cancer

Cancer-screening software wins wireless competition

A software program for screening for cervical cancer, particularly in developing countries with limited resources, earned the top award and $10,000 in the Qualcomm Wireless Innovation Prize at UW-Madison. The AlgoCerv software ...

page 1 from 2